文献速递多重用药认知障碍与谵妄

帕金森病患者潜在不适当用药的频率及危险因素

Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease.
PubMed 文献 · Age Ageing · 2020-01-01

该横断面分析纳入2014年具有A、B、D部分保险的458,086例帕金森病(PD)Medicare受益人,依据2015年Beers标准评估潜在不适当用药(PIM)。35.8%的受益人至少配取一种PIM,8.7%配取可能加重运动症状的PIM,29.0%配取可能加重认知障碍的PIM。调整后,较年轻、女性、白人、城市居住及符合Medicaid资格的受益人更可能接受PIM。

要点

  • 35.8%的帕金森病Medicare受益人至少配取一种PIM。
  • 29.0%的受益人配取可能加重认知障碍的PIM。
  • 较年轻、女性、白人、城市居住及符合Medicaid资格者更可能接受PIM。

核心结论

  • 帕金森病患者中PIM处方并不少见,尤其是可能加重认知障碍的药物。

研究设计与样本

  • 对2014年具有A、B、D部分保险的458,086例帕金森病Medicare受益人进行横断面分析。

主要发现

  • 35.8%的受益人至少配取一种2015年Beers标准定义的老年人PIM。
  • 8.7%的受益人配取可能加重运动症状的PIM。
  • 29.0%的受益人配取可能加重认知障碍的PIM。
  • 调整后,较年轻、女性、白人、城市居住及符合Medicaid资格的受益人更可能接受PIM。

关键数值与推荐

  • PIM定义依据2015年Beers标准。
  • 总体PIM处方频率为35.8%。
  • 可能加重运动症状的PIM频率为8.7%。
  • 可能加重认知障碍的PIM频率为29.0%。

临床怎么用

  • 对帕金森病患者应依据2015年Beers标准筛查PIM,尤其关注可能加重认知障碍的药物。
  • 处方时需注意较年轻、女性、白人、城市居住及符合Medicaid资格的患者可能更易接受PIM。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: impairments in neurotransmitter pathways put Parkinson's disease (PD) patients at risk for drug-disease interactions and adverse medication events. OBJECTIVE: to determine the prevalence and risk factors for potentially inappropriate medication (PIM) prescriptions, as defined by the 2015 Beers List, in PD. METHODS: cross-sectional analysis was conducted on 2014 Medicare beneficiaries with PD who had parts A, B and D coverage. The prevalence of PIM prescriptions for older adults was determined overall, and specifically for medications that can exacerbate motor symptoms or cognitive impairment in PD. Logistic regression models were constructed to determine the association between age, sex, race, geography and poverty with PIM prescriptions. RESULTS: the final sample included 458,086 beneficiaries. In 2014, 35.8% of beneficiaries with PD filled a prescription for at least one PIM for older adults. In total, 8.7% of beneficiaries received a PIM that could exacerbate motor symptoms and 29.0% received a PIM that could worsen cognitive impairment. After adjustment, in all models, beneficiaries who were younger, female, white, urban-dwelling and eligible for Medicaid benefits were more likely to receive a PIM. CONCLUSION: PIM prescriptions are not uncommon in PD, particularly for medications that can exacerbate cognitive impairment. Future research will examine underlying drivers of sex and other disparities in PIM prescribing. Additional studies are needed to understand the impact of PIMs on disease symptoms, healthcare utilisation and patient outcomes.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Abraham DS, Pham Nguyen TP, Hennessy S, et al. Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease. Age Ageing. 2020. PMID: 32255485. doi:10.1093/ageing/afaa033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。